RPHM OnKure Therapeutics, Inc.

Nasdaq onkuretherapeutics.com


$ 3.04 $ -0.22 (-6.96 %)    

Friday, 07-Nov-2025 15:59:53 EST
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 2.94
$ 3.08
$ 2.58 x 3
$ 3.26 x 400
$ 2.60 - $ 3.08
$ 1.70 - $ 17.74
391,768
na
39.83M
$ 1.34
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 03-10-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 03-28-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-27-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 03-23-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-11-2021 06-30-2021 10-Q
19 05-20-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-earlier-reneo-pharmaceuticals-announces-stockholder-approval-of-merger-with-onkure-and-1-for-10-reverse-stock-split

Combined company to trade on Nasdaq under ticker "OKUR" Reneo announces 1-for-10 reverse split of common stock

 reneo-pharmaceuticals-q2-2024-gaap-eps-016-up-from-065-yoy

Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.16) per share. This is a 75.38 percent increase over losse...

 hc-wainwright--co-reiterates-neutral-on-reneo-pharmaceuticals-maintains-15-price-target

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Reneo Pharmaceuticals (NASDAQ:RPHM) with a Neutral and maintains ...

 whats-going-on-with-reneo-pharmaceuticals-stock-today

Reneo and Onkure announced Monday that they have entered into a definitive merger agreement to combine the two companies in an ...

 reneo-pharmaceuticals-q4-gaap-eps-070-misses-062-estimate-cash-cash-equivalents-and-short-term-investments-of-103m

Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate ...

 why-reneo-pharmaceuticals-shares-are-trading-higher-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an ac...

 why-ascent-industries-shares-are-trading-higher-by-7-here-are-20-stocks-moving-premarket

Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the busi...

 reneo-pharmaceuticals-inc-says-on-dec-26-concentra-an-affiliate-of-tang-capital-partners-sent-acquisition-proposal-to-the-co-on-behalf-of-concentra-biosciences-submit-non-binding-proposal-to-acquire-100-of-equity-of-reneo-for-180-per-share

Concentra Biosciences, LLC4747 Executive Drive, Suite 210 | San Diego, CA 92121December 26, 2023Board of DirectorsReneo Pharmac...

 hc-wainwright--co-downgrades-reneo-pharmaceuticals-to-neutral-lowers-price-target-to-15

HC Wainwright & Co. analyst Mitchell Kapoor downgrades Reneo Pharmaceuticals (NASDAQ:RPHM) from Buy to Neutral and lower...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION